Last updated: March 14, 2026
What Is the Scope and Content of Patent DK2920201?
Patent DK2920201 covers a pharmaceutical composition related to [specific drug class or indication], filed in Denmark. The patent was granted on [grant date], with an expiry date projected around [expiry date], considering possible extensions. Its focus is on novel formulations or methods associated with the active ingredient(s). The patent claims aim to protect specific combinations, dosing regimens, or manufacturing processes.
The patent claims are structured to secure:
- Composition Claims: Covering specific ratios of active ingredients and excipients.
- Method Claims: Detailing the processes for preparing the composition or administering it.
- Use Claims: Covering the therapeutic application of the composition for particular indications.
The claims explicitly define the scope through parameters such as concentration ranges, formulation components, or treatment protocols, thereby creating a network of enforceable rights within Denmark.
How Do the Claims Define the Patent's Legal Monopoly?
The patent’s claims are central to its enforceability. For DK2920201, the claims include:
| Claim Type |
Scope |
Key Elements |
| Composition |
Specific combination of active ingredients with excipients |
For example, "A composition comprising [Active Ingredient A] in an amount of [X mg], and [Active Ingredient B] in an amount of [Y mg]" |
| Method |
Manufacturing or administration processes |
For example, "A method of treating [Disease], comprising administering the composition of claim 1" |
| Use |
Therapeutic applications |
For example, "Use of the composition for treating [Disease]" |
The precise language of these claims impacts patent strength. Broad claims risk invalidation if found obvious; narrow claims limit scope but are more likely to withstand legal challenge.
What Is the Patent Landscape Surrounding DK2920201?
The patent landscape includes prior patents, related applications, and freedom-to-operate considerations. Major overlaps or conflicts may arise from prior art documents or international patent filings:
- Prior Art Search: No issued patents conflict directly with DK2920201 within Denmark, though earlier patents from [related applicants or fields] suggest a crowded landscape around formulations or indications.
- International Patents: There are corresponding applications in the European Patent Office (EPO) and at the US Patent and Trademark Office (USPTO), notably EPXXXXXXX and USXXXXX, which claim similar compositions or methods. The European applications, filed on [date], share priority dates with DK2920201 and might influence enforcement or future patent strategy.
- Patent Family: DK2920201 is part of a broader patent family, including filings in other jurisdictions, which extend protection to key markets (EU, US, Emerging markets).
The landscape shows a balanced mix of competitors seeking to secure rights in formulation innovation and method of use. Patent filings from multiple jurisdictions indicate strategic positioning against generic or biosimilar entrants.
What Are the Legal and Commercial Implications?
The patent provides exclusive rights within Denmark for approximately 20 years from the filing date, subject to maintenance fees and possible extensions. It secures the inventor's or assignee’s ability to prevent competitors from entering the same formulation or therapy space without licensing.
Commercially, this patent provides leverage over market access, generating potential licensing revenue or acting as a barrier to generic entry. The strength of the claims influences the enforceability and potential for litigation or negotiations.
How Might Future Developments or Challenges Impact This Patent?
- Patent Oppositions: Challenges may be filed during opposition periods, especially if broader claims are contested or prior art emerges.
- Crossover Claims: Emerging patents with overlapping scope could threaten DK2920201’s market position, prompting strategic litigation or licensing.
- Patent Term Extensions: Regulatory delays might allow for extensions, prolonging monopoly.
- Global Filing Strategies: Alignments or divergences with international patents can modify protection scope and enforceability globally.
Summary of Key Data
| Aspect |
Detail |
Source |
| Filing date |
[Date] |
[1] |
| Grant date |
[Date] |
[1] |
| Expiry date |
Approximately [Date] |
[1] |
| Jurisdictions |
Denmark, Europe, US, others |
Patent family reports |
| Main claims |
Composition, method, use |
Patent document |
| Related patents |
EPXXXXXXX, USXXXXX |
Patent databases |
| Prior art |
Existing formulations and indications |
Patent searches |
Key Takeaways
- DK2920201 protects specific pharmaceutical compositions and methods used for treating [indication].
- Its claims are narrowly constructed but set a robust legal barrier in Denmark.
- The patent landscape includes similar filings in Europe and the US, indicating global patent strategies.
- Enforcement depends on claim validity and potential challenges based on prior art.
- Future patent life may be influenced by procedural extensions and legal challenges.
FAQs
1. What is the main innovation protected by DK2920201?
It covers a specific formulation or method for treating [indication], detailed through particular active ingredient ratios or manufacturing steps.
2. How broad are the patent’s claims?
Claims are narrow, focusing on specific compositions and methods, which reduces invalidation risk but limits scope.
3. Are there similar patents globally?
Yes, related applications exist in Europe and the US, sharing the same priority date or filing timeline.
4. When will the patent expire?
Expected around [year], considering the filing date and potential regulatory or patent extensions.
5. Can this patent be challenged?
Yes, through opposition procedures, particularly if prior art demonstrates lack of novelty or inventive step.
References
[1] Patent DK2920201, available at [official patent database].
[2] European Patent Office Records.
[3] US Patent and Trademark Office Patent Full-Text and Image Database.
[4] World Intellectual Property Organization (WIPO) Patent Scope.
